COMBINED ORAL CONTRACEPTIVES IN TREATMENT OF PATIENTS WITH POLYCYSTIC OVARY SYNDROME
Polycystic Ovary Syndrome (PCOS) presents actual problem in gynecology. In present time discussions on PCOS classification and diagnostics criteria are not completed. Criteria accepted by Rotterdam consensus experts in 2003 year are mostly used. According these criteria PCOS diagnosis is made in cas...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2016-09-01
|
| Series: | Акушерство, гинекология и репродукция |
| Subjects: | |
| Online Access: | https://www.gynecology.su/jour/article/view/312 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849697240809996288 |
|---|---|
| author | M. A. Gevorkyan D. V. Blinov S. O. Smirnova |
| author_facet | M. A. Gevorkyan D. V. Blinov S. O. Smirnova |
| author_sort | M. A. Gevorkyan |
| collection | DOAJ |
| description | Polycystic Ovary Syndrome (PCOS) presents actual problem in gynecology. In present time discussions on PCOS classification and diagnostics criteria are not completed. Criteria accepted by Rotterdam consensus experts in 2003 year are mostly used. According these criteria PCOS diagnosis is made in case when 2 of 3 following signs take place: symptoms of high activity or increased produce of androgens (clinical or biochemical); oligoovulation or anovulation; polycystic ovaries at ultrasound examination. Combined oral contraceptives (COC) play important role in treatment of PCOS. Its reasonable to use monophasic COC, containing the last generation progestogens, like drospirenone. Use of COCs with antiandrogenic activity is pathogenically reasonable and facilitates normalization of luteinizing hormone (LH) level, decreases androgens production in ovaries as well as their size and also has beneficial effect on PCOS symptoms like overweight, hirsutism and acne. |
| format | Article |
| id | doaj-art-7e0e56ce5e57422da3f8e0e9c55d085a |
| institution | DOAJ |
| issn | 2313-7347 2500-3194 |
| language | Russian |
| publishDate | 2016-09-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Акушерство, гинекология и репродукция |
| spelling | doaj-art-7e0e56ce5e57422da3f8e0e9c55d085a2025-08-20T03:19:15ZrusIRBIS LLCАкушерство, гинекология и репродукция2313-73472500-31942016-09-01613949310COMBINED ORAL CONTRACEPTIVES IN TREATMENT OF PATIENTS WITH POLYCYSTIC OVARY SYNDROMEM. A. Gevorkyan0D. V. Blinov1S. O. Smirnova2State Budget Educational Institution of Higher Professional Training «Moscow State Medical Stomatological University» Ministry of Healthсare and Social Development of the Russian FederationState Budget Educational Institution of Higher Professional Training «Russian national Research Medical University named after N.I. Pirogov» Ministry of Healthсare and Social Development of the Russian FederationState Budget Educational Institution of Higher Professional Training «Moscow State Medical Stomatological University» Ministry of Healthсare and Social Development of the Russian FederationPolycystic Ovary Syndrome (PCOS) presents actual problem in gynecology. In present time discussions on PCOS classification and diagnostics criteria are not completed. Criteria accepted by Rotterdam consensus experts in 2003 year are mostly used. According these criteria PCOS diagnosis is made in case when 2 of 3 following signs take place: symptoms of high activity or increased produce of androgens (clinical or biochemical); oligoovulation or anovulation; polycystic ovaries at ultrasound examination. Combined oral contraceptives (COC) play important role in treatment of PCOS. Its reasonable to use monophasic COC, containing the last generation progestogens, like drospirenone. Use of COCs with antiandrogenic activity is pathogenically reasonable and facilitates normalization of luteinizing hormone (LH) level, decreases androgens production in ovaries as well as their size and also has beneficial effect on PCOS symptoms like overweight, hirsutism and acne.https://www.gynecology.su/jour/article/view/312pcoshirsutismacnecocgnrhfshestradioldrospirenone |
| spellingShingle | M. A. Gevorkyan D. V. Blinov S. O. Smirnova COMBINED ORAL CONTRACEPTIVES IN TREATMENT OF PATIENTS WITH POLYCYSTIC OVARY SYNDROME Акушерство, гинекология и репродукция pcos hirsutism acne coc gnrh fsh estradiol drospirenone |
| title | COMBINED ORAL CONTRACEPTIVES IN TREATMENT OF PATIENTS WITH POLYCYSTIC OVARY SYNDROME |
| title_full | COMBINED ORAL CONTRACEPTIVES IN TREATMENT OF PATIENTS WITH POLYCYSTIC OVARY SYNDROME |
| title_fullStr | COMBINED ORAL CONTRACEPTIVES IN TREATMENT OF PATIENTS WITH POLYCYSTIC OVARY SYNDROME |
| title_full_unstemmed | COMBINED ORAL CONTRACEPTIVES IN TREATMENT OF PATIENTS WITH POLYCYSTIC OVARY SYNDROME |
| title_short | COMBINED ORAL CONTRACEPTIVES IN TREATMENT OF PATIENTS WITH POLYCYSTIC OVARY SYNDROME |
| title_sort | combined oral contraceptives in treatment of patients with polycystic ovary syndrome |
| topic | pcos hirsutism acne coc gnrh fsh estradiol drospirenone |
| url | https://www.gynecology.su/jour/article/view/312 |
| work_keys_str_mv | AT magevorkyan combinedoralcontraceptivesintreatmentofpatientswithpolycysticovarysyndrome AT dvblinov combinedoralcontraceptivesintreatmentofpatientswithpolycysticovarysyndrome AT sosmirnova combinedoralcontraceptivesintreatmentofpatientswithpolycysticovarysyndrome |